SCHOTT Pharma Commits €100 Million to Expand Ready-to-Use Sterile Cartridge Manufacturing
SCHOTT Pharma announced a €100 million ($114 million) investment to increase production capacity for ready-to-use sterile cartridges used in injectable medications.
TPG Acquires 35% Stake in SCHOTT Poonawalla for $300 Million, Strengthening Drug Delivery Innovation
US private equity firm TPG, along with co-investor Novo Holdings, has agreed to acquire a 35% stake in SCHOTT Poonawalla from Serum Institute of India (SII) for approximately $300 million, with the deal expected to close in the first half of 2025.